ARRO Profile picture
26 Oct, 5 tweets, 4 min read
Happening now 👉#RadOnc Resident Educational Resources Survey with @ChelainG
✅191 PGY-4 residents + 18 PGY-3 residents from 89 programs for an 81%(!) response rate (100% of programs represented)
✅programs divided into tertiles for further analysis
✅Top tertile with significantly more programs with faculty:resident ratios >1
✅No differences between % of time attendings covered
✅52% of programs without expectations of cross coverage
✅21% of programs with >12 months at required sites away from the main site
✅Top tertile programs more likely to give 12 non-clinical months, 9% of programs give <6 months
✅majority of programs with in-house didactics for radbio/physics
✅Top tertile programs more likely to have more funding
Opportunities:
✅minimum non-clinical time
✅centralized educational resources
✅programs to move towards the "median"

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with ARRO

ARRO Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ARRO_org

27 Oct
Graduating Resident Survey is update & expansion of Practice Entry🌟Response Rate of 94%🌟
98% reported offer for full employment
1% reported entering fellowship
6% non-responders➡️full practice, fellowship, or not employed but🤷they didn't respond.
COVID impacted ~15%
#ASTRO20 ImageImageImage
Median interviews 5⃣ Median offers 2⃣
Networking is 🗝️ in current job market & @ASTRO_org Career Center also helpful‼️
54% Academics, 30% Private, 13% Hospital Employed Community Practices. #ASTRO20 ImageImage
Now let's talk about the 💰
Median *GROUP* for year 1 $300,000-$350,000 and $350,000-$400,000 year 2 (does not rep exact median due to limitations in how data was collected- will be addressed for 2021) #ASTRO20 ImageImage
Read 9 tweets
27 Oct
Starting off with Radiation Oncology Economics by Amar Rewari, MD in the LIVE ARRO Session. Great info for now and also to reference later! #ASTRO20 ImageImage
Physician Work (small portion), Practice Expense (high/majority), and Liability Insurance make up cost of each code. #ASTRO20 Image
Conversion Factor 2020 36 but will be decreased down to 32 for 2021 to achieve budget neutrality, so care will be reimbursed for less next year. ImageImageImage
Read 7 tweets
26 Oct
Starting now: Preserving Radiation Oncology by Investing in Training - panel featuring @emmacfields of @RadOncPDs, @daniel_petereit of @AmericanBrachy, @PottersMD of SCAROP, @NehaVapiwala of @acgme RRC, all moderated by @RTendulkarMD!
First up: the Job Market!
@NehaVapiwala: central regulation from @ASTRO_org and others raises antitrust concerns
@PottersMD: hiring calendar has been pushed back over time, increasing anxiety
Read 12 tweets
26 Oct
Next up at the ARRO Seminar: @DrJohnSuh presents on Becoming an Effective Leader! #ASTRO20
▶️Effectiveness, Efficiency, Engagement to achieve the next level
▶️Good to Great: importance of building the right team, looking at the facts, building the right culture, humility in leadership
▶️improvement is an iterative process:
set goals ➡️review performance ➡️execute to close gaps➡️celebrate success➡️set goals

▶️be aware of the difference between managing and leading
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!